Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 4, 2009, Pages 868-870

  Arhin, Francis F ^a   Sarmiento, Ingrid ^a   Parr, Thomas R ^a   Moeck, Gregory ^a  

^a The Medicines Company   (Canada)

Author keywords

Glycopeptide non susceptible; MBCs; MICs

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; METICILLIN; ORITAVANCIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; GLYCOPEPTIDES; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 70349449330     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp286     Document Type: Letter

References (6)

1. Jones RN. Key considerations in the treatment of complicated staphylococcal infections. Clin Microbiol Infect 2008; 14 Suppl 2: 3-9.
2. Falagas ME, Makris GC, Dimopoulos G et al. Heteroresistance: A concern of increasing significance? Clin Microbiol Infect 2008; 14: 101-4.
3. McKay GA, Beaulieu S, Arhin FF et al. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother 2009; 63: 1191-9.
4. Fritsche TR, Sader HS, Jones RN. Activity of oritavancin tested against contemporary Gram-positive pathogens submitted to a global surveillance program. In: Abstracts of the Forty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America Forty-sixth Annual Meeting, Washington, DC, 2008. Poster C1-142, p. 96. American Society for Microbiology, Washington, DC, USA.
5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18. CLSI, Wayne, PA, USA, 2008.
6. National Committee for Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents - First Edition: Approved Guideline M26-A. NCCLS, Wayne, PA, USA, 1999.